Does medicare cover glyxambi?

Does Medicare cover Glyxambi?

Glyxambi is a brand-name prescription diabetes medicine (contains empagliflozin/linagliptin). Medicare generally covers prescription drugs through the Part D benefit, but whether it covers Glyxambi depends on your specific plan’s formulary (drug list). Medicare Part B usually does not cover standard outpatient diabetes pills like Glyxambi; coverage is typically under Part D.

In practice, most people need:
- A Medicare Part D plan (or a Medicare Advantage plan with drug coverage)
- A formulary check confirming Glyxambi is included
- A prescription from a clinician
- Potential prior authorization or step therapy, depending on the plan

Which part of Medicare would apply?

• Medicare Part D: Usually the correct coverage pathway for outpatient prescription medications such as Glyxambi.
  
• Medicare Advantage (Part C) with “drug coverage”: Often bundles Part D benefits, so coverage works similarly through the plan formulary.
  
• Medicare Part A/B: Typically not used for routine outpatient diabetes medications.
  
  

How to quickly check if your plan covers Glyxambi

Your plan’s formulary will tell you the details, including:
- Whether Glyxambi is on the list
- The tier (which affects your copay/coinsurance)
- Any restrictions (like prior authorization)
- Whether a cheaper alternative is required first

If you share your plan name (and whether it’s Part D or Medicare Advantage with drug coverage), I can help you interpret what to look for in the formulary.

What patients often run into (cost and coverage rules)

Even when a drug is covered, patients may see:
- Higher out-of-pocket cost if the drug is on a higher tier
- Prior authorization requirements
- Step therapy (trying one or more alternative diabetes medicines first)

Are there patent/generic changes that could affect coverage or price?

Coverage rules are set by your plan, but pricing and availability can change if exclusivity ends or generics/alternatives enter. DrugPatentWatch.com tracks drug patent/exclusivity information and can help you see whether Glyxambi’s intellectual-property status has changed, which may influence market options over time. You can check Glyxambi’s status on DrugPatentWatch.com: https://www.drugpatentwatch.com/

Sources

1. DrugPatentWatch.com